Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 176

Sort by

Sort Order Select

Journal Articles

High-Throughput Immunofluorescence and Electron Tomography to Characterize Centrosomal Aberrations in Plasma Cell Neoplasia

Tobias Dittrich, MD, Martin Schorb, Isabella Haberbosch, MD, Elena Bausch, PhD, Mandy Börmel, Marco Cosenza, PhD, Hartmut Goldschmidt, MD, Carsten Müller-Tidow, MD, Marc S Raab, MD PhD, Ute Hegenbart, MD, Stefan O. Schönland, MD, Yannick Schwab, PhD, Alwin Krämer, MD

Blood (2019) 134 (Supplement_1): 3077.

https://doi.org/10.1182/blood-2019-130713

Published: 2019

Journal Articles

A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Steven M. Horwitz, MD, Tatyana A. Feldman, MD, Brian T. Hess, MD, Michael S. Khodadoust, MD PhD, Youn H. Kim, MD, Javier Munoz, MD MS, FACP, Manish R. Patel, MD, Tycel J. Phillips, MD, Stephen D. Smith, MD, Sonali M. Smith, MD, Ryan A. Wilcox, MD PhD, Matt R. Birrell, Janet M. Leeds, PhD, Pamela B. Conley, PhD, Glenn C. Michelson, MD, Gregory P. Coffey, PhD, John T. Curnutte, MD PhD, Paul A. Hamlin, MD

Blood (2019) 134 (Supplement_1): 466.

https://doi.org/10.1182/blood-2019-123986

Published: 2019

Journal Articles

Incidence and Outcomes of Pneumocystis pneumonia When Utilizing PCR-Based Diagnosis in Patients with Hodgkin Lymphoma Receiving Intensive Chemotherapy

Jason N Barreto, PharmD, Carrie A. Thompson, MD, Kristin C. Mara, MS., Amanda G Sierzchulski, PharmD, Ashley L Potter, PharmD, Pritish K Tosh, MD, Andrew H Limper, MD

Blood (2019) 134 (Supplement_1): 4052.

https://doi.org/10.1182/blood-2019-122060

Published: 2019

Journal Articles

Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas

Sanjal Desai, MD, Christopher Melani, MD, Kieron Dunleavy, MD, Stefania Pittaluga, MD PhD, Mark A. Ahlman, MD, Andrea Nicole Lucas, RN, Seth M. Steinberg, PhD, Elaine S. Jaffe, MD, Mark Roschewski, MD, Wyndham Wilson, MD

Blood (2019) 134 (Supplement_1): 4102.

https://doi.org/10.1182/blood-2019-127481

Published: 2019

Journal Articles

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Phani Borra, MD, Cory Edward Mellon, MD

Blood (2019) 134 (Supplement_1): 4905.

https://doi.org/10.1182/blood-2019-128537

Published: 2019

Journal Articles

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

Kazuhiro Toyama, MD PhD, Toshiaki Takezaki, MD, Akira Honda, MD PhD, Yasunori Kogure, MD PhD, Akira Chiba, MD, Fumihiko Nakamura, MD PhD, Kumi Nakazaki, Mineo Kurokawa, MD PhD

Blood (2019) 134 (Supplement_1): 5242.

https://doi.org/10.1182/blood-2019-124597

Published: 2019

Journal Articles

Rezafungin Prevention of Pneumocystis Pneumonia and Pneumocystis reactivation Using Different Doses and Durations of Prophylaxis in a Mouse Model

Melanie T Cushion, PhD MS, Alan Ashbaugh, Voon Ong, PhD

Blood (2019) 134 (Supplement_1): 3266.

https://doi.org/10.1182/blood-2019-127392

Published: 2019

Journal Articles

A Semi-Automated Knime-Based Workflow for High Throughput Quantification and Analysis of Centrosome Aberrations

Tobias Dittrich, MD, Elena Bausch, PhD, Johannes Bausch, PhD, Hartmut Goldschmidt, MD, Ute Hegenbart, MD, Stefan O. Schönland, MD, Marc S Raab, MD PhD, Alwin Krämer, MD

Blood (2019) 134 (Supplement_1): 3379.

https://doi.org/10.1182/blood-2019-129863

Published: 2019

Journal Articles

Fixed Dose Carfilzomib Triplets in Lenalidomide Refractory Myeloma

David Simpson, MBChB, FRACP, FRCPA, Henry Chan, MBChB

Blood (2018) 132 (Supplement 1): 3306.

https://doi.org/10.1182/blood-2018-99-110891

Published: 2018

Journal Articles

Impact of Omitting Prophylactic Antibiotics, to Preserve Gut Microbiota, on the Incidence of Bacteraemia during the Pre-Engraftment Period of Allogenic Hematopoietic Stem Cell Transplantation

Claudie Roy, MD, Simon Frédéric Dufresne, MD FRCP, Miguel Chagnon, M.Sc, P.Stat, Silvy Lachance, MD FRCP

Blood (2018) 132 (Supplement 1): 2094.

https://doi.org/10.1182/blood-2018-99-119525

Published: 2018

Journal Articles

Cumulative Incidence of Blood Stream Infections during Acute Myeloid Leukemia Treatment in the Netherlands: A 15-Year Overview

Emily Risa Schwartz, Sc.B., A.B., Kim Klein, MD MSc, Valerie de Haas, MD PhD, Birgit Lissenberg-Witte, PhD, Lynn Ball, MD, Natasja Dors, MD, Marry M Van den Heuvel-Eibrink, Prof, MD PhD, Rutger Knops, MD, Wim Tissing, MD, Birgitta A. Versluys, MD PhD, Christian M. Zwaan, MD, Raphaele R.L. van Litsenburg, MD PhD, Gertjan J.L. Kaspers, MD PhD

Blood (2018) 132 (Supplement 1): 2685.

https://doi.org/10.1182/blood-2018-99-114364

Published: 2018

Journal Articles

Increased Risk of 100-Day and 1-Year Infection-Related Mortality in Haploidentical Stem Cell Transplantation Patients

Jeremy Chang, MD, Golnaz Vahdani, MD, George Yaghmour, MD, Ashley Weissman, PharmD, Kum-Ja Lee, PharmD, Mojtaba Akhtari, MD

Blood (2018) 132 (Supplement 1): 4630.

https://doi.org/10.1182/blood-2018-99-111404

Published: 2018

Journal Articles

Rituximab for Immune Thrombocytopenia: A Retrospective Analysis on the Role of Prophylaxis Against Pneumocystis Jirovecii and Herpes Zoster Virus

Simona Raso, MD, Mariasanta Napolitano, MD PhD, Melania Carlisi, MD, Salvatrice Mancuso, MD, Marco Santoro, MD, Sergio Siragusa, MD Professor

Blood (2018) 132 (Supplement 1): 4992.

https://doi.org/10.1182/blood-2018-99-118585

Published: 2018

Journal Articles

Prevalence of Folic Acid Deficiency and Cost Effectiveness of Folic Acid Testing: A Single Center Experience

Karina Diaz, Zhu Na, Sorab Gupta, MD, Vikram Arya, Lourdes Martinez, Supreet Dhaliwal, Nora Ajdir, Bhavita Gaglani, Shradha Ahuja, MD, Ilmana Fulger, MD

Blood (2018) 132 (Supplement 1): 4878.

https://doi.org/10.1182/blood-2018-99-111607

Published: 2018

Journal Articles

The Novel SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in a Phase 2a Study in Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Blood (2018) 132 (Supplement 1): 1001.

https://doi.org/10.1182/blood-2018-99-119944

Published: 2018

Journal Articles

Successful Management of Progressive Multifocal Leukoencephalopathy Post TCR Alphabeta/CD19 Depleted Haploidentical Stem Cell Transplant

Satya Prakash Yadav, MBBS, MD, Shruti Kohli, MD, Sagar Nivargi, Dhwanee Thakkar, Neha Rastogi

Blood (2018) 132 (Supplement 1): 5699.

https://doi.org/10.1182/blood-2018-99-119042

Published: 2018

Journal Articles

Prophylaxis of Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia in Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Single Center Experience

Joo Young Ha, MD, Kyoungmin Lee, MD, Jung Yong Hong, Dok Hyun Yoon, Sung-Han Kim, Seongsoo Jang, Chan-Sik Park, Jooryung Huh, Jin-Sook Ryu, Sang-wook Lee, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 5832.

https://doi.org/10.1182/blood-2018-99-118360

Published: 2018

Journal Articles

Evidence Based Recommendations for Supportive Care in Multiple Myeloma

Anum Qureshi, Muhammad Junaid Tariq, MD, Zunairah Shah, MBBS, Muhammad Abu Zar, MD, Shehroz Aslam, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Ahmad Kamal, MD, Jemin Aby Jose, MD, Insija Ilyas Selene, MBBS, Madeeha Shafqat, Faiza Jamil, MD, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1952.

https://doi.org/10.1182/blood-2018-99-110748

Published: 2018

Journal Articles

Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (IDd) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; First Interim Safety Analysis of the Phase II HOVON 143 Study

Claudia A.M. Stege, MD, Kazem Nasserinejad, PhD, Mark-David Levin, MDPhD, Noortje Thielen, MD PhD, Saskia K. Klein, MD PhD, Inge Ludwig, MD MSc, Matthijs Westerman, MD, Paula F Ypma, MDPhD, Yavuz Bilgin, MDPhD, Maaike Sohne, MD, Esther de Waal, PhD, Niels WCJ van de Donk, MD PhD, Pieter Sonneveld, MDPhD, Sonja Zweegman, MDPhD

Blood (2018) 132 (Supplement 1): 596.

https://doi.org/10.1182/blood-2018-99-114668

Published: 2018

Journal Articles

Long-Term Follow up of Front-Line Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide (HiLO trial) for Treatment-Naïve Chronic Lymphocytic Leukemia

Ariel Felipe Grajales-Cruz, MD, Julio C. Chavez, MD, Elyce P. Turba, MSN, RN, Lisa Nodzon, PhD ARNP, AOCNP, Francisco Perez Leal, MD, Jose Sandoval-Sus, MD, Rami S. Komrokji, MD, Frederick L. Locke, MD, Mohamed A Kharfan-Dabaja, MD, Bijal D. Shah, MD, Lubomir Sokol, MD PhD, Celeste M. Bello, MD, Javier Pinilla Ibarz, MD

Blood (2018) 132 (Supplement 1): 3150.

https://doi.org/10.1182/blood-2018-99-111564

Published: 2018

NARROW

High-Throughput Immunofluorescence and Electron Tomography to Characterize Centrosomal Aberrations in Plasma Cell Neoplasia

A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Incidence and Outcomes of Pneumocystis pneumonia When Utilizing PCR-Based Diagnosis in Patients with Hodgkin Lymphoma Receiving Intensive Chemotherapy

Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Optimal Cycles of Bendamustine-Plus Rituximab Therapy for Indolent B Cell Lymphoma

Rezafungin Prevention of Pneumocystis Pneumonia and Pneumocystis reactivation Using Different Doses and Durations of Prophylaxis in a Mouse Model

A Semi-Automated Knime-Based Workflow for High Throughput Quantification and Analysis of Centrosome Aberrations

Fixed Dose Carfilzomib Triplets in Lenalidomide Refractory Myeloma

Impact of Omitting Prophylactic Antibiotics, to Preserve Gut Microbiota, on the Incidence of Bacteraemia during the Pre-Engraftment Period of Allogenic Hematopoietic Stem Cell Transplantation

Cumulative Incidence of Blood Stream Infections during Acute Myeloid Leukemia Treatment in the Netherlands: A 15-Year Overview

Increased Risk of 100-Day and 1-Year Infection-Related Mortality in Haploidentical Stem Cell Transplantation Patients

Rituximab for Immune Thrombocytopenia: A Retrospective Analysis on the Role of Prophylaxis Against Pneumocystis Jirovecii and Herpes Zoster Virus

Prevalence of Folic Acid Deficiency and Cost Effectiveness of Folic Acid Testing: A Single Center Experience

The Novel SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in a Phase 2a Study in Relapsed/Refractory Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Successful Management of Progressive Multifocal Leukoencephalopathy Post TCR Alphabeta/CD19 Depleted Haploidentical Stem Cell Transplant

Prophylaxis of Trimethoprim-Sulfamethoxazole for Pneumocystis Pneumonia in Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Single Center Experience

Evidence Based Recommendations for Supportive Care in Multiple Myeloma

Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (IDd) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; First Interim Safety Analysis of the Phase II HOVON 143 Study

Long-Term Follow up of Front-Line Therapy with Ofatumumab, High Dose Methylprednisolone and Lenalidomide (HiLO trial) for Treatment-Naïve Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only